Highlights from the NCRI Conference 2013

2013-11-11 00:00:00

Staff from CRT recently attended the NCRI Cancer Conference 2013 – the leading cancer research meeting in the UK. Started in 2005 to provide a forum for researchers from different disciplines to exchange knowledge and ideas, the conference programme showcases the best in basic science, clinical trials, qualitative research and dataset analysis. Here some of the CRT team share their highlights from this year’s event:

  • “From the perspective of immunotherapy for cancer, I thought the presentations from both Dr Lisa Coussens and Dr Doug Fearon were provocative and contained new insights.” Clive Stanway, Chief Scientific Officer
  • “Dr Sean Morrison’s talk on palliative care was very thought provoking. It put into perspective the money spent on developing new medicines relative to gains offered by implementing better mechanisms for palliative care.” Martyn Bottomley, Business Development
  • “I enjoyed Dr Charles Swanton’s talk on chromosomal instability and ‘hopeful monsters’. It was interesting to hear about cancer discussed from an evolutionary point of view and how this can impact on the genetic make-up of tumours at different sites within a single patient but also within different parts of a single tumour.” Laura Dickens, Business Development
  • “Professor Gerard Evan’s plenary lecture on finding the best targets for treating cancer was really interesting. I think one of the take home messages was that we shouldn’t be too quick to disregard targets based on assumptions of toxicity.” Kath Fowler, CRT-DL Senior Scientist
  • “Dr Stephen West gave an excellent talk on his fascinating work to unravel the mechanism of action of BRCA2 using X-ray crystallography and electron microscopy, and showed that BRCA2 acts as a chaperone protein in the DNA repair process.” Pritom Shah, CRT-DL Group Leader

Notes to editors